Optimizing PrEP Uptake and Adherence Among Male Sex Workers

NCT ID: NCT05736614

Last Updated: 2025-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-03

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

"PrEPare for Work" is a randomized controlled trial (RCT) whose goal is to test the efficacy of a behavioral intervention (Short Title: PrEPare for Work) in improving PrEP uptake, adherence, and persistence among male sex workers (MSW)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A theory-based, manualized intervention -called "PrEPare for Work"-includes two separate but complementary interventions that address MSW-specific behavioral, economic, interpersonal \& structural-level barriers to accessing and adhering to PrEP: 1) peer-led, strengths-based case management (SBCM) for PrEP linkage and uptake; and 2) a technology and counseling intervention to optimize PrEP adherence (once they have access to PrEP). This research will test the PrEPare for Work intervention in a fully-powered RCT to assess efficacy and cost-effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Controlled Trial (RCT)

Study arms:

1. Stage 1 Standard of Care (SOC) Control Condition
2. Stage 1 Strength Based Case Management (SBCM) Condition
3. Stage 2 SOC Control Condition
4. Stage 2 PrEPare for Work Intervention Condition
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stage 1 Standard of Care (SOC) Control Condition

SOC participants will receive an informational pamphlet about the PrEP as a form of HIV prevention and referrals to local PrEP Prescribers.

Group Type NO_INTERVENTION

No interventions assigned to this group

Stage 1 Strength Based Case Management (SBCM) Condition

Intervention participants will receive a trained SBCM to motivate, support, and assist in linkage to PrEP prescribers to help facilitate obtaining PrEP medication to initiate treatment.

Group Type EXPERIMENTAL

Stage 1 Strength Based Case Management (SBCM) Condition

Intervention Type BEHAVIORAL

Intervention participants will receive a trained SBCM to motivate, support, and assist in linkage to PrEP prescribers to help facilitate obtaining PrEP medication to initiate treatment.

Stage 2 SOC Control Condition

Research staff will show a brief video that describes what PrEP is and how it works to prevent HIV via sexual and injection transmission. Participants will continue to see their PrEP prescriber for routine clinical care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Stage 2 PrEPare for Work Intervention Condition

Intervention participants will receive 1-on-1 adherence counseling and personalized daily text messaging reminders to increase PrEP adherence. Intervention participants will undergo three adherence intervention sessions (once per week for 3 weeks) with interventionist.

Group Type EXPERIMENTAL

Stage 2 PrEPare for Work Intervention Condition

Intervention Type BEHAVIORAL

Intervention participants will receive 1-on-1 adherence counseling and personalized daily text messaging reminders to increase PrEP adherence. Intervention participants will undergo three adherence intervention sessions (once per week for 3 weeks) with interventionist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stage 1 Strength Based Case Management (SBCM) Condition

Intervention participants will receive a trained SBCM to motivate, support, and assist in linkage to PrEP prescribers to help facilitate obtaining PrEP medication to initiate treatment.

Intervention Type BEHAVIORAL

Stage 2 PrEPare for Work Intervention Condition

Intervention participants will receive 1-on-1 adherence counseling and personalized daily text messaging reminders to increase PrEP adherence. Intervention participants will undergo three adherence intervention sessions (once per week for 3 weeks) with interventionist.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 18 years or older
* Assigned male sex at birth
* Identifies as male at enrollment
* Report having engaged in condomless anal sex with another man in the past 3 months
* Report having exchanged sex for money, drugs, items of value, or a place to stay with another man in the past 3 months
* Report HIV status as negative or unsure
* Not currently on PrEP
* Able to understand and speak English or Spanish

Exclusion

* Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of interview (will use an adapted version of the Evaluation to Sign Consent Form65 to assess capacity)
* Discovery of active suicidal ideation or major mental illness (e.g. untreated psychosis or mania) at the time of interview (these patients will be referred immediately for treatment)
* Laboratory or clinical findings that would preclude PrEP initiation (e.g. Chronic Hepatitis B Virus infection, decreased creatinine clearance)
* Participated in the pilot RCT and initiated PrEP during study participation
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Miriam Hospital

OTHER

Sponsor Role collaborator

University of California, Los Angeles

OTHER

Sponsor Role collaborator

Project Weber/RENEW

UNKNOWN

Sponsor Role collaborator

Open Door Health

UNKNOWN

Sponsor Role collaborator

National Institute of Nursing Research (NINR)

NIH

Sponsor Role collaborator

Brown University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Katie Biello, PhD

Role: PRINCIPAL_INVESTIGATOR

Brown University School of Public Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UCLA Fielding School of Public Health

Los Angeles, California, United States

Site Status RECRUITING

The Miriam Hospital

Providence, Rhode Island, United States

Site Status RECRUITING

Open Door Health

Providence, Rhode Island, United States

Site Status RECRUITING

Project Weber/RENEW

Providence, Rhode Island, United States

Site Status RECRUITING

Brown University School of Public Health

Providence, Rhode Island, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Katie Biello, PhD

Role: CONTACT

401-863-3082

Matthew Mimiaga, ScD MPH

Role: CONTACT

617 901 9276

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eun Kwak

Role: primary

Philip A Chan, MD

Role: primary

401-793-2928

Philip Chan, MD

Role: primary

1-401-648-4700

Colleen Daley Ndoye

Role: primary

(401) 383-4888

Vanessa Silva

Role: primary

Katie Biello, PhD

Role: backup

401 863 3082

References

Explore related publications, articles, or registry entries linked to this study.

Biello KB, Chan PA, Ndoye CD, Nelson L, Nelson E, Silva V, Kwak E, Napoleon S, Cormack Orellana C, Richards OG, Davis E, Mimiaga MJ. Study protocol of a randomized controlled trial to assess the efficacy of the "PrEPare for Work" intervention to enhance PrEP uptake and optimize adherence for HIV prevention among male sex workers in the U.S. BMC Public Health. 2024 Feb 9;24(1):424. doi: 10.1186/s12889-024-17710-y.

Reference Type DERIVED
PMID: 38336731 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01NR020227

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2001002627

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MI-based PrEP Intervention
NCT03313765 COMPLETED NA
Life Steps for PrEP for Youth
NCT03805451 COMPLETED NA
PrEP iT! Mobile App Intervention
NCT04509076 COMPLETED NA